Although it has been clarified that gene mutations in these splicing factors are involved in carcinogenesis by causing different and specific aberrant splicing, recent studies have demonstrated that there is a unifying mechanism underlying the etiology of MDS harboring mutations in SF3B1, SRSF2, and U2AF1. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.